MRNA Competitors & Rivals
Compare Moderna Inc with top Biotechnology companies
Moderna Inc
MRNA - Health Care
Market Cap
$20.9B
Price
$53.57
P/E Ratio
N/A
Revenue Growth
-0.3%
Top Competitors
Side-by-Side Comparison
| Metric | MRNA | AAPL | MSFT | GOOGL |
|---|---|---|---|---|
| Price | $53.57 | $264.55 | $397.23 | $315.20 |
| Market Cap | $20.9B | N/A | N/A | N/A |
| P/E Ratio | N/A | 33.85 | 24.58 | 28.58 |
| Revenue Growth | -0.3% | 6.4% | 0.2% | 15.1% |
| Profit Margin | -1.5% | 0.3% | 0.4% | 0.3% |
Detailed Head-to-Head Comparisons
Get in-depth analysis comparing MRNA with each competitor
Frequently Asked Questions
Who are MRNA's main competitors?
MRNA's main competitors include AAPL, MSFT, GOOGL, and other companies in the Biotechnology industry. These companies compete directly with Moderna Inc for market share and customers.
How does MRNA compare to its competitors?
MRNA can be compared to competitors using metrics like market capitalization, P/E ratio, revenue growth, profit margins, and market share. Each competitor has different strengths - some may have better valuations while others have higher growth rates.
What are the best alternatives to MRNA stock?
The best alternatives to MRNA depend on your investment goals. For similar market exposure, consider AAPL or MSFT. For different risk profiles, research companies with varying market caps and growth trajectories in the Biotechnology sector.
Which is better: MRNA or AAPL?
Comparing MRNA vs AAPL requires analyzing valuation metrics, growth prospects, competitive advantages, and risk factors. Neither is universally "better" - the right choice depends on your investment strategy, risk tolerance, and market outlook.
What makes MRNA different from its competitors?
Moderna Inc differentiates itself through its unique business model, product offerings, market positioning, and competitive advantages. Factors like brand strength, innovation, operational efficiency, and financial health distinguish MRNA from rivals.
Should I diversify across MRNA and its competitors?
Diversifying across multiple companies in the same industry can reduce company-specific risk while maintaining sector exposure. However, this doesn't eliminate sector risk. Consider diversifying across different industries and sectors for better risk-adjusted returns.
Continue Your Research
Explore more analysis tools for MRNA